Evidence-Based Medicine Guidelines
Iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Iloprost and Cisaprost for Raynaud's Phenomenon in Progressive Systemic Sclerosis." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/451691/all/Iloprost_and_cisaprost_for_Raynaud&apos.
Iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosis. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/451691/all/Iloprost_and_cisaprost_for_Raynaud&apos. Accessed February 7, 2026.
Iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosis. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/451691/all/Iloprost_and_cisaprost_for_Raynaud&apos
Iloprost and Cisaprost for Raynaud's Phenomenon in Progressive Systemic Sclerosis [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2026 February 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/451691/all/Iloprost_and_cisaprost_for_Raynaud&apos.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosis
ID - 451691
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451691/all/Iloprost_and_cisaprost_for_Raynaud&apos
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
